Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing safety/activity with novel therapies.
University of Iowa Holden Comprehensive Cancer Center | Strategic Alliance Partners
Latest from University of Iowa Holden Comprehensive Cancer Center
Advertisement
Advertisement
Trending on CURE
1
FDA Fast Tracks HDP-101 For Multiple Myeloma
2
Music Therapy Shown to Ease Cancer Survivors’ Anxiety
3
Five-Time Survivor Reflects on Bladder Cancer: ‘There’s Always Hope’
4
What Aging Previvors Can Teach Us About Staving Off Cancer
5
